New imaging agent could sharpen detection of rare tumors
NCT ID NCT02134639
First seen Jun 14, 2026 · Last updated Jun 14, 2026
Summary
This early-phase study tested a new radioactive tracer called 68Ga-DOTATOC for PET-CT scans in 20 adults suspected of having neuroendocrine tumors. The goal was to see if this new method could find tumors more accurately than the current standard scan (OctreoScan). Researchers also checked if the tracer was safe and if the production process was reliable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bordeaux
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.